GlassScriptPhysician profile
Stephen E Kuehn
NPI 1124020508
$1,905.57
in general payments reported to CMS, 2019-2025
24 companies · $99.80 in 2025
The $99.80 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,235 · 2020: $138 · 2021: $433 · 2025: $99.80.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $99.80.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $99.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $371.45 | 2019 | |
| Abbvie INC. | $324.14 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $161.00 | 2019-2021 | |
| Gilead Sciences, INC. | $136.01 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $120.51 | 2019 | |
| Daiichi Sankyo INC. | $113.42 | 2021 | |
| Janssen Biotech, INC. | $103.89 | 2019-2021 | |
| Edwards Lifesciences Corporation | $99.80 | 2025 | Sapien 3 Ultra Resilia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $95.43 | 2019-2021 | |
| Allergan, INC. | $79.85 | 2019 | |
| Pfizer INC. | $61.63 | 2019-2020 | |
| Shionogi INC | $43.43 | 2019-2020 | |
| Intercept Pharmaceuticals, INC. | $32.19 | 2019 | |
| Olympus America INC. | $28.39 | 2019 | |
| Braintree Laboratories, INC. | $26.14 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $16.35 | 2019 | |
| Shire North American Group INC | $15.07 | 2019 | |
| Redhill Biopharma INC. | $13.94 | 2021 | |
| Celgene Corporation | $13.71 | 2021 | |
| Ironwood Pharmaceuticals, INC | $12.97 | 2021 | |
| Alfasigma USA, INC. | $12.67 | 2020 | |
| Axonics, INC. | $11.89 | 2021 | |
| Merck Sharp & Dohme LLC | $10.97 | 2019 | |
| Romark Laboratories, Lc | $0.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kuehn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.